MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

CT Algorithm Diagnoses Clear-Cell Renal Cell Carcinoma in Small Solid Masses

By MedImaging International staff writers
Posted on 30 Jun 2022

A 5-tiered CT scoring algorithm may represent a clinically useful tool for diagnosis of clear-cell renal cell carcinoma (RCC) in small solid renal masses.

Researchers at The Ottawa Hospital (Ontario, Canada) conducted a study that included 148 patients (mean age, 58 years; 73 men, 75 women) with 148 small (≤4 cm) solid (>25% enhancing tissue) renal masses that underwent renal-mass CT (unenhanced, corticomedullary, and nephrographic phases) before resection between January 2016 and December 2019. Two radiologists independently evaluated the CT examinations and recorded calcification, mass attenuation in all phases, mass-to-cortex corticomedullary attenuation ratio, and heterogeneity score (5-point Likert scale, assessed in corticomedullary phase).


Image: A 5-tiered CT scoring algorithm can diagnose clear-cell renal cell carcinoma in small solid masses (Photo courtesy of Pexels)
Image: A 5-tiered CT scoring algorithm can diagnose clear-cell renal cell carcinoma in small solid masses (Photo courtesy of Pexels)

The study revealed that the 5-tiered CT scoring algorithm - including mass-to-cortex corticomedullary attenuation ratio and heterogeneity score - had substantial interobserver agreement (weighted kappa=0.71) and achieved AUC for diagnosing clear-cell RCC of 0.75 (95% CI, 0.68-0.82) for reader 1 and 0.72 (95% CI, 0.66-0.82) for reader 2.

“A 5-tiered renal CT algorithm, including mass-to-cortex corticomedullary attenuation ratio and heterogeneity score, had substantial inter-observer agreement, moderate AUC and PPV, and high NPV for diagnosing clear-cell RCC,” concluded Nicola Schieda from the department of medical imaging at Canada’s Ottawa Hospital.

“If validated,” the researchers acknowledged, “the CT algorithm may represent a useful clinical tool for diagnosing clear-cell renal cell carcinoma."

Related Links:
The Ottawa Hospital


X-ray Diagnostic System
FDX Visionary-A
Ultrasonic Pocket Doppler
SD1
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Biopsy Software
Affirm® Contrast

Latest General/Advanced Imaging News

New Proton Therapy Platform Integrates into Existing Radiotherapy Departments
30 Jun 2022  |   General/Advanced Imaging

3D-Printed Intraoral Device Enhances Head and Neck Radiotherapy Accuracy
30 Jun 2022  |   General/Advanced Imaging

Molecular Imaging Agent Shows Promise for Endometriosis Detection and Monitoring
30 Jun 2022  |   General/Advanced Imaging